Bringing the Promise of Artificial Intelligence to Critical Care: What the Experience With Sepsis Analytics Can Teach Us.

"Dr. Wardi received funding from Northwest Anesthesia and Medicolegal consulting. Drs. Wardi, Malhotra, and Nemati received support for article research from the National Institutes of Health (NIH). Dr. Malhotra’s institution received funding from ResMed; he received funding from the NIH, Livanova, Eli Lilly, Zoll, and Jazz. Drs. Malhotra and Nemati disclosed that they are cofounders and equity shareholders in Healcisio, Inc. Dr. Josef received funding from Healcisio, Inc. Dr. Longhurst disclosed that he is an equity shareholder in Doximity. Dr. Owens has disclosed that he does not have any potential conflicts of interest."

"Dr. Wardi received funding from Northwest Anesthesia and Medicolegal consulting. Drs. Wardi, Malhotra, and Nemati received support for article research from the National Institutes of Health (NIH). Dr. Malhotra’s institution received funding from ResMed; he received funding from the NIH, Livanova, Eli Lilly, Zoll, and Jazz. Drs. Malhotra and Nemati disclosed that they are cofounders and equity shareholders in Healcisio, Inc. Dr. Josef received funding from Healcisio, Inc. Dr. Longhurst disclosed that he is an equity shareholder in Doximity. Dr. Owens has disclosed that he does not have any potential conflicts of interest."